Immune Checkpoint Inhibitors Market by Type of Immune Checkpoint Proteins (PD-1, PD-L1, CTLA-4, and Others), by Target Disease Indication (Lung Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer, Colorectal Cancer, Melanoma, Hodgkin Lymphoma, and Others), Type of Therapeutic Modality (Antibody Fragments, Monoclonal Antibodies, Small Molecules, and Other Modalities), Route of Administration, Geographical Regions, and Leading Players – Trends and Forecast, 2026-2035